From a technical perspective, Cramer and Moreno both agreed that the daily chart of Abbott Laboratories was “a beautiful picture.”

“In fact, Moreno says it’s a picture-perfect uptrend, [with the] stock steadily rising above its 50-day moving average,” Cramer added.

Even though shares have recently been trading sideways, Moreno noticed that the relative strength indicator, which measures momentum, has issued some bullish readings, signaling that the health care stock could soon break out above its $55.50 ceiling and keep running higher.